-
Study aim
-
Comparison of the efficacy of oral and intranasal midazolam premedication on sedation before undergoing MRI in children
-
Design
-
This study will be conducted as a randomized, controlled, double-blind (outcome evaluator and statistical analyzer), 3-arm phase 3 clinical trial with parallel groups, on 90 eligible patients. The table of random numbers provided by graphpad.com will be used for randomization.
-
Settings and conduct
-
This clinical trial will be conducted on eligible patients admitting to pediatric medical center, Tehran. Pre-sedation will be administered in the preparation room and anesthesia will be performed in the MRI room; Patients will randomly divided into one of 3 control , oral Midazolam and intranasal midazolam groups, and after receiving the intervention, the intended outcomes will be evaluated. In this study, the outcome evaluator and the statistical analyst are unaware of the type of groups.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: ASA class 1 to 2 according to the American Society of Anesthesiologists; Age is between 6 months to 6 years; The patient is a candidate for MRI under anesthesia;
Exclusion criteria: The patient has upper gastrointestinal tract problems, or an active infection, or a structural disorders of the upper respiratory system, or patient is cyanotic, or Having a history of drug allergy, or Severe crying and restlessness of the child immediately before participation;.
-
Intervention groups
-
Group 1: 0.5 mg/kg syrup Midazolam PO, 20 minutes prior parental separation to conducting anesthesia
Group 2: 0.2 mg/kg nasal spray Midazolam intranasal, 20 minutes prior parental separation to conducting anesthesia
Group 3 (Control group): routine anesthesia, without pre-sedation
Routine anesthesia: induction with inhaled sevoflurane and 1ml/kg intravenous Propofol
-
Main outcome variables
-
Sedation scale